Picard Medical posts presentation transcript for Annual Meeting

Picard Medical, Inc. posted a pre-recorded presentation providing an overview of recent business performance, product development progress, manufacturing initiatives, and proposals for its 2026 Annual Meeting of Stockholders.

Accepted by SEC EDGAR 07/02/2026 - 05:28 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Picard Medical, Inc. posted a pre-recorded presentation providing an overview of recent business performance, product development progress, manufacturing initiatives, and proposals for its 2026 Annual Meeting of Stockholders. The Presentation transcript is attached as Exhibit 99.1 and is incorporated by reference. The Annual Meeting is scheduled for July 17, 2026.

Key Figures

Filing date: July 2, 2026 Annual Meeting date: July 17, 2026 Exhibit attached: Exhibit 99.1 +2 more

5 metrics

Filing date July 2, 2026 Date of this Current Report on Form 8-K

Annual Meeting date July 17, 2026 2026 Annual Meeting of Stockholders

Exhibit attached Exhibit 99.1 Presentation transcript (July 2, 2026)

Inline XBRL cover Exhibit 104 Cover Page Interactive Data File embedded

Form reference Form 8-K (Section 13/15(d)) Current Report format used for disclosure

Key Terms

Presentation transcript, Exhibit 99.1, Inline XBRL

3 terms

Presentation transcript regulatory

"A copy of the transcript for the Presentation is attached hereto as Exhibit 99.1"

Exhibit 99.1 regulatory

"Exhibit No. 99.1 | Presentation transcript (July 2, 2026)"

Exhibit 99.1 is a label used in regulatory filings to identify a specific attached document, most often a company press release or investor presentation filed with securities regulators. For investors it matters because it marks an official, contemporaneous source of information directly tied to a filing—like the original news article pinned to a legal record—so traders and analysts treat it as an authoritative statement that can move a stock or clarify a company’s situation.

Inline XBRL technical

"Cover Page Interactive Data File (embedded within the Inline XBRL document)"

Inline XBRL is a file format for financial filings that embeds machine-readable data tags directly inside the human-readable report, so the same document can be read by people and parsed by software. For investors it makes extracting, comparing and verifying financial numbers faster and more reliable—like a grocery list where each item also has a barcode—reducing manual errors and speeding up analysis.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Picard Medical (PMI) disclose in its July 2, 2026 8-K?

The company published a pre-recorded presentation transcript attached as Exhibit 99.1. It covers business performance, product development, manufacturing initiatives, and proposals for the July 17, 2026 Annual Meeting.

When is Picard Medical's 2026 Annual Meeting of Stockholders?

The Annual Meeting is scheduled for July 17, 2026. The July 2, 2026 presentation summarizes items and proposals to be considered at that meeting.

Where can I find the Presentation transcript referenced by Picard Medical?

The transcript is filed with the 8-K as Exhibit 99.1. The report states the transcript is incorporated by reference in the Form 8-K dated July 2, 2026.

Does the 8-K include financial statements or numerical results?

No financial statements or numeric financial results are included in this 8-K. The filing references a presentation transcript focused on operations and proposals, not periodic financial tables.

What exhibits accompany Picard Medical's 8-K filing on July 2, 2026?

The filing lists Exhibit 99.1 (Presentation transcript, July 2, 2026) and an Inline XBRL cover page file as Exhibit 104 in the 8-K exhibit table.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): July 2, 2026

Picard Medical, Inc.

(Exact name of registrant as specified in its charter)

Delaware		001-42801		86-3212894
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

1992 E Silverlake
Tucson, AZ 85713

(Address of principal executive offices, including zip code)

Registrant’s telephone number, including area code: (520) 545-1234

Not Applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☒	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, par value $0.0001 per share		PMI		The NYSE American, LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 8.01 Other Events. 

As previously disclosed in Picard Medical, Inc.'s (the "Company") Current Report on Form 8-K filed on July 2, 2026, the Company published a pre-recorded presentation (the “Presentation”) providing stockholders with an overview of the Company's recent business performance, product development progress, manufacturing initiatives, and the proposals to be considered at the Company's 2026 Annual Meeting of Stockholders, scheduled for July 17, 2026. The Presentation is incorporated herein by reference. A copy of the transcript for the Presentation is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

The following exhibits are being filed herewith:

Exhibit No.		Description
99.1		Presentation transcript (July 2, 2026)
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

1

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	Picard Medical, Inc.
	By:	/s/ Georgina Smith
	Name:	Georgina Smith
	Title:	Chief Accounting Officer

Dated: July 2, 2026

2